BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15699742)

  • 1. Mixed hematopoietic chimerism for the simultaneous induction of T and B cell tolerance.
    Sykes M; Shimizu I; Kawahara T
    Transplantation; 2005 Feb; 79(3 Suppl):S28-9. PubMed ID: 15699742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell and B cell tolerance to GALalpha1,3GAL-expressing heart xenografts is achieved in alpha1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism.
    Ohdan H; Yang YG; Swenson KG; Kitamura H; Sykes M
    Transplantation; 2001 Jun; 71(11):1532-42. PubMed ID: 11435961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerization of Gal alpha 1,3Gal-reactive B cells in pre-sensitized alpha 1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism.
    Ohdan H; Swenson KG; Kitamura H; Yang YG; Sykes M
    Xenotransplantation; 2001 Nov; 8(4):227-38. PubMed ID: 11737848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed chimerism induced without lethal conditioning prevents T cell- and anti-Gal alpha 1,3Gal-mediated graft rejection.
    Ohdan H; Yang YG; Shimizu A; Swenson KG; Sykes M
    J Clin Invest; 1999 Aug; 104(3):281-90. PubMed ID: 10430609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerization of anti-Galalpha1-3Gal natural antibody-forming B cells by induction of mixed chimerism.
    Yang YG; deGoma E; Ohdan H; Bracy JL; Xu Y; Iacomini J; Thall AD; Sykes M
    J Exp Med; 1998 Apr; 187(8):1335-42. PubMed ID: 9547344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of cyclophosphamide-induced tolerance in alpha1,3-galactosyltransferase knockout mice presensitized with Gal alpha 1-3Gal beta-4-GlcNAc antigens.
    Onzuka T; Shimizu I; Tomita Y; Iwai T; Okano S; Tominaga R
    Surg Today; 2008; 38(9):807-14. PubMed ID: 18751946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High antigen levels do not preclude B-cell tolerance induction to alpha1,3-Gal via mixed chimerism.
    Haspot F; Bardwell PD; Zhao G; Sykes M
    Xenotransplantation; 2008; 15(5):313-20. PubMed ID: 19134161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mixed chimerism induces donor-specific T-cell tolerance across a highly disparate xenogeneic barrier.
    Abe M; Qi J; Sykes M; Yang YG
    Blood; 2002 May; 99(10):3823-9. PubMed ID: 11986242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed chimerism.
    Sykes M; Sachs DH
    Philos Trans R Soc Lond B Biol Sci; 2001 May; 356(1409):707-26. PubMed ID: 11375074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed allogeneic chimerism in the rat. Donor-specific transplantation tolerance without chronic rejection for primarily vascularized cardiac allografts.
    Colson YL; Zadach K; Nalesnik M; Ildstad ST
    Transplantation; 1995 Nov; 60(9):971-80. PubMed ID: 7491703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of xenogeneic stem cells for induction of transplantation tolerance: present state and future directions.
    Yang YG
    Springer Semin Immunopathol; 2004 Nov; 26(1-2):187-200. PubMed ID: 15378269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-cell extrinsic CR1/CR2 promotes natural antibody production and tolerance induction of anti-alphaGAL-producing B-1 cells.
    Shimizu I; Kawahara T; Haspot F; Bardwell PD; Carroll MC; Sykes M
    Blood; 2007 Feb; 109(4):1773-81. PubMed ID: 17023586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic cell transplantation for the induction of allo- and xenotolerance.
    Sykes M
    Clin Transplant; 1996 Aug; 10(4):357-63. PubMed ID: 8884109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic chimerism and tolerance of T cells, B cells, and NK cells.
    Sykes M; Ohdan H; Manilay JO; Wekerle T; Yang YG
    Transplant Proc; 1998 Dec; 30(8):4020. PubMed ID: 9865282
    [No Abstract]   [Full Text] [Related]  

  • 16. Mixed chimerism as an approach to transplantation tolerance.
    Sachs DH
    Clin Immunol; 2000 Apr; 95(1 Pt 2):S63-8. PubMed ID: 10729238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Mixed Xenogeneic Porcine Hematopoietic Chimerism on Human NK Cell Recognition in a Humanized Mouse Model.
    Li HW; Vishwasrao P; Hölzl MA; Chen S; Choi G; Zhao G; Sykes M
    Am J Transplant; 2017 Feb; 17(2):353-364. PubMed ID: 27401926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differing mechanisms of early and late B cell hyporesponsiveness induced by mixed chimerism.
    Kawahara T; Shimizu I; Ohdan H; Zhao G; Sykes M
    Am J Transplant; 2005 Dec; 5(12):2821-9. PubMed ID: 16302994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixed xenogeneic porcine chimerism tolerizes human anti-pig natural antibody-producing cells in a humanized mouse model.
    Waffarn EE; Khosravi-Maharlooei M; Vecchione A; Shao S; Vishwasrao P; HÖlzl MA; Frangaj K; Sykes M; Li HW
    Xenotransplantation; 2021 Jul; 28(4):e12691. PubMed ID: 33904221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.